Search research articles
Contact Us
Filters
Showing results (161-170 of 513) with videos related to
Page
of 52
Sort By:
Oncotarget
|
February 25, 2016
The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma
Bo Mi Ku, Seong Yoon Yi, Jiae Koh, et al.
Cancer Research and Treatment
|
May 30, 2018
Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer
Jiyun Lee, Joon Ho Shim, Woong-Yang Park, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 24, 2018
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma
Jiyun Lee, Hyun Ae Jung, Youjin Kim, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 7, 2020
Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer
Hyun Ae Jung, Jae Myoung Noh, Jong-Mu Sun, et al.
Computer Methods and Programs in Biomedicine
|
July 3, 2025
Unraveling the tumor-microenvironment through a radiogenomic-based multiomic approach to predict outcomes of immunotherapy in non-small cell lung cancer
Dong Young Jeong, Cheol Yong Joe, Sang Min Lee, et al.
Head & Neck
|
April 3, 2009
Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma
Kyubo Kim, Hong-Gyun Wu, Hak Jae Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 12, 2020
Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NSCLC With Leptomeningeal Metastases Regardless of T790M Mutational Status
Jiyun Lee, Yoon La Choi, Joungho Han, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 21, 2015
A Prospective Phase II Study of Cisplatin and Cremophor EL-Free Paclitaxel (Genexol-PM) in Patients with Unresectable Thymic Epithelial Tumors
Hae Su Kim, Ji Yun Lee, Sung Hee Lim, et al.
Cancer Biomarkers : Section a of Disease Markers
|
April 11, 2016
Pretreatment albumin-to-globulin ratio as a predictive marker for tyrosine kinase inhibitor in non-small cell lung cancer
Sehhoon Park, Seongyeol Park, Se-Hoon Lee, et al.
Cancer Research and Treatment
|
March 13, 2015
Gefitinib-Induced Interstitial Lung Disease in Korean Lung Cancer Patients
Seung-Hoon Beom, Dong-Wan Kim, Sung Hoon Sim, et al.
Page
of 52
Search research articles
Search
Showing results (161-170 of 513) with videos related to
Sort By:
Page
of 52
Oncotarget
|
February 25, 2016
The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma
Bo Mi Ku, Seong Yoon Yi, Jiae Koh, et al.
Cancer Research and Treatment
|
May 30, 2018
Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer
Jiyun Lee, Joon Ho Shim, Woong-Yang Park, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 24, 2018
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma
Jiyun Lee, Hyun Ae Jung, Youjin Kim, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 7, 2020
Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer
Hyun Ae Jung, Jae Myoung Noh, Jong-Mu Sun, et al.
Computer Methods and Programs in Biomedicine
|
July 3, 2025
Unraveling the tumor-microenvironment through a radiogenomic-based multiomic approach to predict outcomes of immunotherapy in non-small cell lung cancer
Dong Young Jeong, Cheol Yong Joe, Sang Min Lee, et al.
Head & Neck
|
April 3, 2009
Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma
Kyubo Kim, Hong-Gyun Wu, Hak Jae Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 12, 2020
Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NSCLC With Leptomeningeal Metastases Regardless of T790M Mutational Status
Jiyun Lee, Yoon La Choi, Joungho Han, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 21, 2015
A Prospective Phase II Study of Cisplatin and Cremophor EL-Free Paclitaxel (Genexol-PM) in Patients with Unresectable Thymic Epithelial Tumors
Hae Su Kim, Ji Yun Lee, Sung Hee Lim, et al.
Cancer Biomarkers : Section a of Disease Markers
|
April 11, 2016
Pretreatment albumin-to-globulin ratio as a predictive marker for tyrosine kinase inhibitor in non-small cell lung cancer
Sehhoon Park, Seongyeol Park, Se-Hoon Lee, et al.
Cancer Research and Treatment
|
March 13, 2015
Gefitinib-Induced Interstitial Lung Disease in Korean Lung Cancer Patients
Seung-Hoon Beom, Dong-Wan Kim, Sung Hoon Sim, et al.
Page
of 52